3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
6
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
598
INDUSTRY
385
NETWORK
78
NIH
65
OTHER_GOV
6
UNKNOWN
1
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Interventions
S 1 (combination)
7
Cisplatin
7
Radiotherapy, Intensity-Modulated
5
Paclitaxel
5
Oxaliplatin
3
Irinotecan
3
Capecitabine
3
titanium silicide
2
raltitrexed
2
nimotuzumab
2
nabiximols
2
Radiotherapy
2
Radiation Dose Hypofractionation
2
pegylated granulocyte colony-stimulating factor
1
nedaplatin
1
icaritin
1
gimeracil
1
anlotinib
1
Trastuzumab
1
Temozolomide
1
Tegafur
1
TP protocol
1
Surgical Procedures, Operative
1
Radiotherapy, Adjuvant
1
Radiation
1
Pharmaceutical Preparations
1
Pemetrexed
1
Ondansetron
1
Methylene Blue
1
Lidocaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
UNKNOWN
×
Docetaxel
×
Clear all
NCT02725424
2022-08-17
MATCH
ChineseAMS
Phase 2
Completed
180 enrolled